Bibliographic Info
GuidelineGuidelines for treatment of drug-susceptible tuberculosis and patient care
Year of Publication2017
Issuing InstitutionWorld Health Organization
Recommendation
Status
Maintained
Recommended in favor
Conditional
Certainty of evidence
Very low
A decentralized model of care is recommended over a centralized model for patients on multidrug-resistant tuberculosis (MDR-TB) treatment
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO guidelines on tuberculosis infection prevention and control: 2019 update
Year2019
InstitutionWHO
Guideline
WHO consolidated guidelines on drug-resistant tuberculosis treatment
Year2019
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update
Year2022
InstitutionWorld Health Organization
Guideline
WHO consolidated guidelines on tuberculosis: module 4: treatment and care
Year2025
InstitutionWorld Health Organization